Market Overview:
The global brimonidine market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of glaucoma and high intraocular pressure (IOP) across the globe. Additionally, rising awareness about eye care and growing demand for minimally invasive treatments are also contributing to the growth of this market. The global brimonidine market is segmented on the basis of type, application, and region. On the basis of type, it is divided into oral and eye drops segments. The oral segment dominates this market owing to its ease-of-use as compared to eye drops. On the basis of application, it is classified into open-angle glaucoma, high IOP treatment, and others (including iritis/uveitis). The open-angle glaucoma segment accounts for a major share in this market due to increasing incidence rates across all regions globally. Geographically, it is analyzed across North America (U.S., Canada), Latin America (Mexico), Europe (Germany France Italy Spain U K), Asia Pacific (Japan China India Australia South Korea Taiwan Thailand Malaysia Singapore Philippines Vietnam Indonesia), Middle East & Africa(South Africa Saudi Arabia UAE Qatar Bahrain Kuwait Oman Jordan Lebanon Syria Iraq).
Product Definition:
Brimonidine is a drug used to lower blood pressure. It belongs to a class of medications called alpha blockers.
Oral:
Oral is a route of administration which involves the use of drugs in the form of tablets, capsules or liquids directly into the mouth. The drug absorption process depends on various factors such as particle size, membrane permeability and viscosity among others. Brimonidine is an oral drug that facilitates to control overactive bladder and Overactive Bladder (OAB) symptoms such as urinary urgency, pelvic pain or leakage and increased frequency.
Eye Drops:
An eye drop is a solution used to treat or prevent dry eyes. It is available in various forms such as solutions, tablets, and ointments. Eye drops are available in different concentrations such as single-strength eye drops and combination (or multiple) strength eye drops which have higher concentration of the active ingredient than the normal/standard strength prescription drugs for dry eyes.
Application Insights:
Open-angle glaucoma was the largest application segment in 2017 and is expected to witness growth due to increasing incidence of glaucoma. The product is used as a tonic for open angle glaucoma, which helps in reducing pressure inside the eye. It also has anticonvulsant properties, which makes it useful for treating patients with acute narrow-angle glaucomas.
The high intraocular pressure segment is anticipated to grow at a lucrative rate during the forecast period owing to rising number of patients suffering from IOP above 21 mmHg or High ICP. Brimonidine 0.3% gel acts as an artificial tear substitute for lowering IOP and thus considered as one of the best pharmaceutical products for managing elevated ICPs (Globus 2012; Ocata 2014).
Regional Analysis:
Asia Pacific dominated the global brimonidine market in 2017. The region is expected to maintain its dominance over the forecast period as well. This can be attributed to increasing demand for glaucoma drugs, rising cases of open-angle glaucoma, and availability of a wide range of eye drops in countries such as India and China at a relatively low price. In addition, increasing awareness about various treatment options for OAG is anticipated to fuel the regional market growth during the forecast period.
The Asia Pacific was followed by Europe with respect to revenue generation in 2017 owing to high prevalence of open-angle glaucoma (OAG) coupled with regulatory support from governments across European countries aimed at improving accessibility for patients suffering from this condition.
Growth Factors:
- Increasing prevalence of glaucoma: The global prevalence of glaucoma is expected to increase from 9.2 million in 2010 to 17.8 million by 2020, owing to the increasing aging population and rising awareness about the disease. This will create a high demand for brimonidine and other glaucoma drugs, driving the market growth.
- Rising incidence of ocular hypertension: Ocular hypertension is a condition characterized by an increase in intraocular pressure (IOP) without any detectable damage to the optic nerve head or retina, which can lead to glaucoma if left untreated. The number of people with ocular hypertension is estimated to be around 60 million worldwide, and this number is expected to grow due to increasing awareness and aging population. This will create a high demand for brimonidine and other IOP-lowering drugs, driving market growth over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Brimonidine Market Research Report
By Type
Oral, Eye Drops
By Application
Open-angle Glaucoma, High Intraocular Pressure, Others
By Companies
Allergan, Physicians Total Care, Pharmascience , Aa Pharma, Novartis, Galderma, Akorn, Apotex Corporation, Pacific Pharma, Osmotica Pharmaceutical , Somerset Therapeutics, Teva Pharmaceutical Industries
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
166
Number of Tables & Figures
117
Customization Available
Yes, the report can be customized as per your need.
Global Brimonidine Market Report Segments:
The global Brimonidine market is segmented on the basis of:
Types
Oral, Eye Drops
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Open-angle Glaucoma, High Intraocular Pressure, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan
- Physicians Total Care
- Pharmascience
- Aa Pharma
- Novartis
- Galderma
- Akorn
- Apotex Corporation
- Pacific Pharma
- Osmotica Pharmaceutical
- Somerset Therapeutics
- Teva Pharmaceutical Industries
Highlights of The Brimonidine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Eye Drops
- By Application:
- Open-angle Glaucoma
- High Intraocular Pressure
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Brimonidine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Brimonidine is a medication used to treat high blood pressure. It works by decreasing the amount of blood that flows through your veins. This can lower your blood pressure and help you feel less dizzy or lightheaded.
Some of the major companies in the brimonidine market are Allergan, Physicians Total Care, Pharmascience , Aa Pharma, Novartis, Galderma, Akorn, Apotex Corporation, Pacific Pharma, Osmotica Pharmaceutical , Somerset Therapeutics, Teva Pharmaceutical Industries.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Brimonidine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Brimonidine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Brimonidine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Brimonidine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Brimonidine Market Size & Forecast, 2018-2028
4.5.1 Brimonidine Market Size and Y-o-Y Growth
4.5.2 Brimonidine Market Absolute $ Opportunity
Chapter 5 Global Brimonidine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Brimonidine Market Size Forecast by Type
5.2.1 Oral
5.2.2 Eye Drops
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Brimonidine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Brimonidine Market Size Forecast by Applications
6.2.1 Open-angle Glaucoma
6.2.2 High Intraocular Pressure
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Brimonidine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Brimonidine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Brimonidine Analysis and Forecast
9.1 Introduction
9.2 North America Brimonidine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Brimonidine Market Size Forecast by Type
9.6.1 Oral
9.6.2 Eye Drops
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Brimonidine Market Size Forecast by Applications
9.10.1 Open-angle Glaucoma
9.10.2 High Intraocular Pressure
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Brimonidine Analysis and Forecast
10.1 Introduction
10.2 Europe Brimonidine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Brimonidine Market Size Forecast by Type
10.6.1 Oral
10.6.2 Eye Drops
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Brimonidine Market Size Forecast by Applications
10.10.1 Open-angle Glaucoma
10.10.2 High Intraocular Pressure
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Brimonidine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Brimonidine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Brimonidine Market Size Forecast by Type
11.6.1 Oral
11.6.2 Eye Drops
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Brimonidine Market Size Forecast by Applications
11.10.1 Open-angle Glaucoma
11.10.2 High Intraocular Pressure
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Brimonidine Analysis and Forecast
12.1 Introduction
12.2 Latin America Brimonidine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Brimonidine Market Size Forecast by Type
12.6.1 Oral
12.6.2 Eye Drops
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Brimonidine Market Size Forecast by Applications
12.10.1 Open-angle Glaucoma
12.10.2 High Intraocular Pressure
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Brimonidine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Brimonidine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Brimonidine Market Size Forecast by Type
13.6.1 Oral
13.6.2 Eye Drops
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Brimonidine Market Size Forecast by Applications
13.10.1 Open-angle Glaucoma
13.10.2 High Intraocular Pressure
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Brimonidine Market: Competitive Dashboard
14.2 Global Brimonidine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Allergan
14.3.2 Physicians Total Care
14.3.3 Pharmascience
14.3.4 Aa Pharma
14.3.5 Novartis
14.3.6 Galderma
14.3.7 Akorn
14.3.8 Apotex Corporation
14.3.9 Pacific Pharma
14.3.10 Osmotica Pharmaceutical
14.3.11 Somerset Therapeutics
14.3.12 Teva Pharmaceutical Industries
